InvestorsHub Logo
Followers 27
Posts 2742
Boards Moderated 0
Alias Born 03/17/2017

Re: None

Monday, 07/24/2017 9:36:45 AM

Monday, July 24, 2017 9:36:45 AM

Post# of 6399
“Mytesi achieves much greater reductions in HIV-related diarrhea than was apparent in the ADVENT primary responder analysis,” commented Dr. Rodger D. MacArthur, Medical College of Georgia, Augusta, GA. “Most patients saw meaningful reductions in diarrhea, with more than 75 percent experiencing at least a 50 percent reduction and more than half of patients experiencing complete resolution of diarrhea at week 24. I think it is important to note that results were consistent regardless of use of a protease inhibitor or the cause of the diarrhea.”

(1) https://finance.yahoo.com/news/data-shows-dramatic-reduction-chronic-130000785.html
(2) http://mytesi.com/clinical-results.html
(3) New Handout http://mytesi.com/assets/ias_crofelemer_eposter_and_handout_jul_2017.pdf
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent JAGX News